Form D · Pharmaceuticals

Axxia Pharmaceuticals, LLC

Bel Air, MD · CIK 0001514545

Offering snapshot reported Feb 2, 2017 · SEC filing

Reported sold
Yet to sell
Offering amount: $3M
Investors reported
0
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 2, 2017InitialYet to sellNo comparison0SEC filing
Feb 14, 2013InitialYet to sellNo comparison0SEC filing
Mar 12, 2012Initial$300,000No comparison1SEC filing
Sep 23, 2011InitialYet to sellNo comparison0SEC filing
Apr 1, 2011Initial$100,000No comparison8SEC filing
Mar 4, 2011Initial$150,000No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-279846

Source: Form D, filed Feb 2, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas E Byrne Director
D. Phillip Cox Director, Executive
Wally Grimm Director
Stuart Grossman Director
Sally Mac Connell Director
Wayne Pollock Director, Executive
Bernard Rudnick Director, Executive
June Sy Director
Jun Sy Director
Julio D. Sy, Jr. Director
David Wheatley Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2614 West Medical Hall Road
Bel Air, MD, 21015